Kerr WG - Search Results

1

SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.

Desponts C, Hazen AL, Paraiso KH, Kerr WG. Desponts C, et al. Among authors: kerr wg. Blood. 2006 Jun 1;107(11):4338-45. doi: 10.1182/blood-2005-12-5021. Epub 2006 Feb 7. Blood. 2006. PMID: 16467196 Free PMC article.

2

Role of c-mpl in early hematopoiesis.

Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, Eaton DL. Solar GP, et al. Among authors: kerr wg. Blood. 1998 Jul 1;92(1):4-10. Blood. 1998. PMID: 9639492 Free article.

3

Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein.

Tu Z, Ninos JM, Ma Z, Wang JW, Lemos MP, Desponts C, Ghansah T, Howson JM, Kerr WG. Tu Z, et al. Among authors: kerr wg. Blood. 2001 Oct 1;98(7):2028-38. doi: 10.1182/blood.v98.7.2028. Blood. 2001. PMID: 11567986 Free article.

4

Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.

Wang JW, Howson JM, Ghansah T, Desponts C, Ninos JM, May SL, Nguyen KH, Toyama-Sorimachi N, Kerr WG. Wang JW, et al. Among authors: kerr wg. Science. 2002 Mar 15;295(5562):2094-7. doi: 10.1126/science.1068438. Science. 2002. PMID: 11896280

5

Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses.

Ghansah T, Paraiso KH, Highfill S, Desponts C, May S, McIntosh JK, Wang JW, Ninos J, Brayer J, Cheng F, Sotomayor E, Kerr WG. Ghansah T, et al. Among authors: kerr wg. J Immunol. 2004 Dec 15;173(12):7324-30. doi: 10.4049/jimmunol.173.12.7324. J Immunol. 2004. PMID: 15585856

6

Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.

Zhu K, Gerbino E, Beaupre DM, Mackley PA, Muro-Cacho C, Beam C, Hamilton AD, Lichtenheld MG, Kerr WG, Dalton W, Alsina M, Sebti SM. Zhu K, et al. Among authors: kerr wg. Blood. 2005 Jun 15;105(12):4759-66. doi: 10.1182/blood-2004-11-4307. Epub 2005 Feb 22. Blood. 2005. PMID: 15728126 Free PMC article.

7

Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.

Wahle JA, Paraiso KH, Costello AL, Goll EL, Sentman CL, Kerr WG. Wahle JA, et al. Among authors: kerr wg. J Immunol. 2006 Jun 15;176(12):7165-9. doi: 10.4049/jimmunol.176.12.7165. J Immunol. 2006. PMID: 16751359

8

s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival.

Desponts C, Ninos JM, Kerr WG. Desponts C, et al. Among authors: kerr wg. Stem Cells Dev. 2006 Oct;15(5):641-6. doi: 10.1089/scd.2006.15.641. Stem Cells Dev. 2006. PMID: 17105399

9

Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease.

Paraiso KH, Ghansah T, Costello A, Engelman RW, Kerr WG. Paraiso KH, et al. Among authors: kerr wg. J Immunol. 2007 Mar 1;178(5):2893-900. doi: 10.4049/jimmunol.178.5.2893. J Immunol. 2007. PMID: 17312133

10

Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell.

Wahle JA, Paraiso KH, Kendig RD, Lawrence HR, Chen L, Wu J, Kerr WG. Wahle JA, et al. Among authors: kerr wg. J Immunol. 2007 Dec 15;179(12):8009-15. doi: 10.4049/jimmunol.179.12.8009. J Immunol. 2007. PMID: 18056340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters